Prognostic value of high-resolution electrocardiography parameters, heart rate variability, and QT interval dynamics in patients with chronic heart failure

Aim. To study prognostic value of high-resolution electrocardiography (HR-ECG), heart rate variability (HRV), QT interval dispersion and duration parameters, for assessing the risk of chronic heart failure (CHF) decompensation, atrial fibrillation (AF), and sudden cardiac death (SCD) in coronary heart disease (CHD) patients. Material and methods. In total, 70 patients with various CHD forms, Functional Class II-III CHF (NYHA), and documented AF paroxysms in anamnesis, were examined. Instrumental examination included 24-hour ECG monitoring, echocardiography, ECG, HR-ECG, HRV assessment. Results. During prognostic follow-up, the participants were divided into groups, according to disease course and clinical outcome. End-points included: CHF decompensation, resulted in hospitalization; arrhythmic complications - prolonged AF paroxysms; SCD. Assessing prognostic value of HR-ECG, HRV and QT interval duration in predicting CHF decompensation, ECG predictors with maximal positive prognostic value were filtered QRS complex duration and corrected maximal QT interval. In predicting AF paroxysms, HR-ECG parameter, filtered P wave duration, had maximal prognostic value. Conclusion. Non-invasive ECG-diagnostics methods: HR-ECG, HRV and QT interval duration assessment, could be used in predicting arrhythmic complication and decompensation risk among CHD patients with CHF.

1. Вариабельность сердечного ритма: стандарты измерения, физиологической интерпретации и клинического использования. Pекомендации Европейского Кардиологического общества. Вест аритм 1999; 11: 53-78.

2. Иванов Г.Г., Сметнев А.С., Простакова Т.С. Поздние потенциалы и спектрально-временное картирование предсердного зубца Р у больных с пароксизмальной формой мерцательной аритмии. Кардиология 1996; 11: 43-8.

3. Кузнецов А.А. Клиническая и прогностическая значимость длительности и вариабельности интервалов QT и RR (клиническое популяционное исследование). Автореф дисс докт мед наук. Новосибирск 1999.

4. Рябыкина Г.В., Соболев А.В. Мониторирование ЭКГ с анализом вариабельности ритма сердца. Москва ИД «Медпрактика-М» 2005; 224с.

5. Соболев А.В. Проблемы количественной оценки вариабельности ритма сердца при холтеровском мониторировании. Вест аритм 2002; 26: 21-5.

6. Электрокардиография высокого разрешения. Под редакцией Г.Г. Иванова, С.В.Грачева, А.Л. Сыркина. Москва «Триада-Х» 2003; 304 с.

7. Abboud S. High frequency electrocardiogram analysis of the entire QRS in the diagnosis and assessment of coronary artery desease. Progr Cardiovasc Dis 1993; 35(4): 311-27.

8. Anastasiou-Nana MI, Nanas JN, Karagounis LA, et al. Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. Am J of Cardiol 2000; 85: 1212-7.

9. Brendorp B, Elming H, Jun L, et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 2001; 13: 831-5.

10. Brooksby P, Batin PD, Nolan J, et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. Eur Heart J 1999; 20: 1335-41.

11. De Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998; 97: 467-72.

12. Dekker JM, Schouten EG, Klootwijk P, et al. Association between QT interval and coronary heart desease in middle-aged and elderly men. The Zutphen Study. Circulation 1994; 90: 779-85.

13. Denes P, El-Sherif N, Katz R, et al. Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST Substudy). Am J Cardiol 1994; 74: 216-20.

14. Fukunami M, Yamada T, Ohmoni M, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythms by P wave-triggered signal-avereged electrocardiogram. Circulation 1991; 83; 162-9.

15. Galinier M, Vialette J-C, Fourcade J, et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Eur Heart J 1998; 19: 1054-62.

16. Langan MN, Horowitz LN, Simson MB. A Q-wave infarction necessary for the generation of a late potential? JACC 1990; 15: 38A.

17. Manttari M, Oikarinen L, Manninen V, et al. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997; 78: 268-72.

18. Ogawa H, Inoue T, Miwa S, et al. Problems on evaluating signalaveraged P wave as a predictor of atrial fibrillation or flutter – the importance of frequency range of the filter and the influence of left atrial overload. Japan Circulation J 1989; 53: 490-8.

19. Savelieva I, Yap YG, Yi G, et al. Comparative reproducibility of QT, OT peak, and T peak-T end intervals and dispersion in normal subjects, patients with myocardial infarction and patients with hypertrophic cardiomyopathy. Pace 1998; Part II, 21: 2376- 81.

20. Schouten EG, Dekker JM, Meppelink P. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516-23.

21. Vatterott PJ, Wiltgen CM, Hammill SC. The importance of a Qwave infarct in the development of late potentials. JACC 1990; 15: 37A.

22. Рекомендации Европейского общества кардиологов. Рекомендации по диагностике и лечению хронической сердечной недостаточности. Серд недостат 2001; 2(6): 251-77.

23. Мареев B.Ю. Первые результаты Российского эпидемиологического исследования по ХСН. Серд недостат 2003; 4(1) (17): 17-8.

24. Национальные Рекомендации по диагностике и лечению хронической сердечной недостаточности (утверждены съездом кардиологов РФ в октябре 2003). Серд недостат 2003; 4(6) (22): 276-98.

25. Нестеренко Л.Ю., Мазыгула Е.П., Голицын С.П. Принципы лечения желудочковых нарушений ритма сердца у больных с сердечной недостаточностью. Серд недостат 2001; 2(5): http://www.consilium-medicum.com

26. ACC/AHA TASK FORCE HEART FAILURE GUIDELINES. Guidelines for the Evaluation and Management of Heart Failure Report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). JACC 1995; 26(5): 1376-98.